Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01045759
Other study ID # 1143800
Secondary ID
Status Terminated
Phase N/A
First received January 7, 2010
Last updated September 29, 2016
Start date November 2009
Est. completion date May 2015

Study information

Verified date September 2016
Source University of Missouri-Columbia
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

We propose an observational study to assess the ability of intensivists to evaluate for deep vein thrombosis using 2 point compression ultrasonography.


Description:

Deep vein thrombosis is a common problem in the intensive care unit and diagnosis is often delayed due to limited availability of a formal duplex ultrasound. Physician performed 2 point compression ultrasonography has been shown to have reasonable accuracy when performed in the emergency department and outpatient setting, but has not been studied on patients in the intensive care unit. We propose an observational study to assess the ability of intensivists to evaluate for deep vein thrombosis using 2 point compression ultrasonography.


Recruitment information / eligibility

Status Terminated
Enrollment 150
Est. completion date May 2015
Est. primary completion date May 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Male and female adults at least 18 years of age

- Duplex ultrasonography ordered by treating team

- Admission to the Medical, Cardiac, Burn, or Surgical intensive care units

Exclusion Criteria:

- Patients less than 18 years of age

- Patients with a known current DVT

- patients on whom the exam cannot be performed (above the knee amputation, severe cellulitis of groin or popliteal fossa, hip or knee fracture)

Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States University of missouri healthcare Columbia Missouri

Sponsors (1)

Lead Sponsor Collaborator
University of Missouri-Columbia

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The agreement between physician performed ultrasound and formal duplex ultrasonography for detection of proximal deep vein thrombosis. 48 hours window from detailed US No
Secondary Subgroup analysis: location of thrombus (proximal or distal) 48 hours window from detailed US No
Secondary Subgroup analysis: number of days in the hospital prior to exam 48 hours window from detailed US No
Secondary Subgroup analysis: body mass index (BMI) 48 hours window from detailed US No
Secondary Subgroup analysis: weight gain from admission to the time of the exam 48 hours window from detailed US No
Secondary Subgroup analysis: training level of examiner 48 hours window from detailed US No
Secondary Subgroup analysis: difficulty of exam 48 hours window from detailed US No
Secondary Subgroup analysis: specific examiner 48 hours window from detailed US No
Secondary Subgroup analysis: presence or absence of calf vein thrombosis at study conclusion No
Secondary Subgroup analysis: presence or absence of pulmonary embolism at study conclusion No
Secondary Subgroup analysis: DVT location at study conclusion No
Secondary Subgroup analysis: calf vein thrombosis at study conclusion No
See also
  Status Clinical Trial Phase
Recruiting NCT05003843 - BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis N/A
Recruiting NCT03937947 - Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study
Withdrawn NCT04136561 - Novel Strategy to Encourage Early Removal of Central Venous Catheters N/A
Completed NCT03420625 - Blood Flow Stimulation in the Lower Limbs by Application of Different External Devices N/A
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Completed NCT02555111 - Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis. Phase 3
Terminated NCT02469376 - Evaluation of a New Imagingtechnologie for Thrombosis Phase 1
Completed NCT01975090 - The SENTRY Clinical Study N/A
Completed NCT02037607 - Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical Procedures N/A
Not yet recruiting NCT01357941 - Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE) N/A
Completed NCT00771303 - Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study
Completed NCT00773448 - Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism N/A
Completed NCT00720915 - D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months N/A
Completed NCT00244725 - Odiparcil For The Prevention Of Venous Thromboembolism Phase 2
Completed NCT00264277 - D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism Phase 4
Completed NCT00365950 - 3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE Phase 4
Completed NCT00182403 - Fixed Dose Heparin Study Phase 3
Completed NCT03682419 - Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device (OPTIMAL) N/A
Not yet recruiting NCT04981327 - The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis Phase 3
Recruiting NCT03240120 - A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism Phase 3